BioStem Technologies, Inc.
BSEM
Rank in Stocks
#26305
BioStem Technologies, Inc. engages in the development, manufacturing, and... BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Share Price
$1.12
Last synced: 2026-11-09
Market Cap
$20.91M
Change (1 day)
-0.88%
Change (1 year)
-75.49%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioStem Technologies, Inc. (BSEM)
Category
Healthcare
EPS for BioStem Technologies, Inc. (BSEM)
EPS as of June 2026 TTM: $-1.66
According to BioStem Technologies, Inc.'s latest financial reports, its current EPS (TTM) is $-1.66. At the end of 2025 the company had an EPS of $-0.39, a decrease compared to its 2024 EPS of $1.95.
EPS history for BioStem Technologies, Inc. from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.66 | 325.64% |
| 2025 | $-0.39 | -120.00% |
| 2024 | $1.95 | -414.52% |
| 2023 | $-0.62 | -1.59% |
| 2022 | $-0.63 | 320.00% |
| 2021 | $-0.15 | -42.31% |
| 2020 | $-0.26 | -62.32% |
| 2019 | $-0.69 | -26.60% |
| 2018 | $-0.94 | -1.05% |
| 2017 | $-0.95 | -11.21% |
| 2016 | $-1.07 | -47.80% |
| 2015 | $-2.05 | 876.19% |
| 2014 | $-0.21 | -93.73% |
| 2013 | $-3.35 | -97.92% |
| 2012 | $-160.89 | 532.68% |
| 2011 | $-25.43 | 73.94% |
| 2010 | $-14.62 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,043.37% |
US
|
|
| $-7.07 | 325.90% |
US
|
|
| $-5.29 | 218.67% |
AU
|
|
| $12.88 | -875.91% |
BE
|
|
| $21.56 | -1,398.80% |
NL
|
Questions about BioStem Technologies, Inc.'s earnings per share (EPS)
What is BioStem Technologies, Inc.'s earnings per share (EPS)?
BioStem Technologies, Inc.'s earnings per share (EPS) over the last twelve months is $-1.66, as of Jun 2026.
What was BioStem Technologies, Inc.'s earnings per share (EPS) in 2025?
In 2025, BioStem Technologies, Inc.'s earnings per share (EPS) was $-0.39, compared with $1.95 in 2024.
How has BioStem Technologies, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, BioStem Technologies, Inc.'s earnings per share (EPS) was highest in 2024 ($1.95) and lowest in 2022 ($-0.63).
How does BioStem Technologies, Inc.'s earnings per share (EPS) compare with similar companies?
BioStem Technologies, Inc.'s earnings per share (EPS) ($-1.66) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.